Literature DB >> 10587987

Body dysmorphic disorder and depression: theoretical considerations and treatment strategies.

K A Phillips1.   

Abstract

Body dysmorphic disorder (BDD), also known as dysmorphophobia, consists of a distressing and impairing preoccupation with an imagined or slight defect in appearance. BDD is an underrecognized and relatively common disorder that is associated with high rates of occupational and social impairment, hospitalization, and suicide attempts. BDD is unlikely to simply be a symptom of depression, although it often coexists with depression and may be related to depression. It is important to recognize BDD in depressed patients, because missing the diagnosis can result in refractory BDD and depressive symptoms. Available data indicate that BDD may not respond to all treatments for depression and may instead respond preferentially to serotonin-reuptake inhibitors. In addition, lengthier treatment trials than those required for depression may be needed to successfully treat BDD and comorbid depression. It can be difficult and challenging to diagnose BDD in depressed patients because the symptoms are often concealed due to embarrassment and shame. This paper discusses the relationship between BDD and depression and discusses practical strategies for recognizing and treating BDD and depressive symptoms in patients with depression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10587987     DOI: 10.1023/a:1022090200057

Source DB:  PubMed          Journal:  Psychiatr Q        ISSN: 0033-2720


  35 in total

Review 1.  Treatment of body-dysmorphic disorder with serotonin reuptake blockers.

Authors:  E Hollander; M R Liebowitz; R Winchel; A Klumker; D F Klein
Journal:  Am J Psychiatry       Date:  1989-06       Impact factor: 18.112

2.  Heuristic models of comorbidity of axis I and axis II disorders.

Authors:  M J Lyons; P Tyrer; J Gunderson; M Tohen
Journal:  J Pers Disord       Date:  1997

3.  Perceived stress in body dysmorphic disorder.

Authors:  L M DeMarco; L C Li; K A Phillips; S L McElroy
Journal:  J Nerv Ment Dis       Date:  1998-11       Impact factor: 2.254

4.  Efficacy and safety of fluvoxamine in body dysmorphic disorder.

Authors:  K A Phillips; M M Dwight; S L McElroy
Journal:  J Clin Psychiatry       Date:  1998-04       Impact factor: 4.384

5.  Thirty-three cases of body dysmorphic disorder in children and adolescents.

Authors:  R S Albertini; K A Phillips
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1999-04       Impact factor: 8.829

6.  The high prevalence of "soft" bipolar (II) features in atypical depression.

Authors:  G Perugi; H S Akiskal; L Lattanzi; D Cecconi; C Mastrocinque; A Patronelli; S Vignoli; E Bemi
Journal:  Compr Psychiatry       Date:  1998 Mar-Apr       Impact factor: 3.735

7.  Muscle dysmorphia. An underrecognized form of body dysmorphic disorder.

Authors:  H G Pope; A J Gruber; P Choi; R Olivardia; K A Phillips
Journal:  Psychosomatics       Date:  1997 Nov-Dec       Impact factor: 2.386

8.  Dermatological non-disease: a common and potentially fatal disturbance of cutaneous body image.

Authors:  J A Cotterill
Journal:  Br J Dermatol       Date:  1981-06       Impact factor: 9.302

9.  A study of depression and obsessionality in dysmorphophobic and psoriatic patients.

Authors:  G E Hardy; J A Cotterill
Journal:  Br J Psychiatry       Date:  1982-01       Impact factor: 9.319

10.  Body dysmorphic disorder in patients with anxiety disorders and major depression: a comorbidity study.

Authors:  O Brawman-Mintzer; R B Lydiard; K A Phillips; A Morton; V Czepowicz; N Emmanuel; G Villareal; M Johnson; J C Ballenger
Journal:  Am J Psychiatry       Date:  1995-11       Impact factor: 18.112

View more
  9 in total

Review 1.  Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V?

Authors:  Katharine A Phillips; Dan J Stein; Scott L Rauch; Eric Hollander; Brian A Fallon; Arthur Barsky; Naomi Fineberg; David Mataix-Cols; Ygor Arzeno Ferrão; Sanjaya Saxena; Sabine Wilhelm; Megan M Kelly; Lee Anna Clark; Anthony Pinto; O Joseph Bienvenu; Joanne Farrow; James Leckman
Journal:  Depress Anxiety       Date:  2010-06       Impact factor: 6.505

2.  Associations in the longitudinal course of body dysmorphic disorder with major depression, obsessive-compulsive disorder, and social phobia.

Authors:  Katharine A Phillips; Robert L Stout
Journal:  J Psychiatr Res       Date:  2005-11-23       Impact factor: 4.791

Review 3.  Cognitive-behavioral therapy for youth with body dysmorphic disorder: current status and future directions.

Authors:  Katharine A Phillips; Jamison Rogers
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2011-04

4.  Functional recovery of daily living and sports activities after cosmetic bilateral tibia lengthening.

Authors:  Kun-Bo Park; Yoon Hae Kwak; Jung Woo Lee; Byoung Kyu Park; Hoon Park; Dong Hoon Lee
Journal:  Int Orthop       Date:  2018-10-11       Impact factor: 3.075

5.  Cosmetic lower limb lengthening by Ilizarov apparatus: what are the risks?

Authors:  Konstantin I Novikov; Koushik N Subramanyam; Serghei O Muradisinov; Olga S Novikova; Elina S Kolesnikova
Journal:  Clin Orthop Relat Res       Date:  2014-09-03       Impact factor: 4.176

Review 6.  Shame in the obsessive compulsive related disorders: a conceptual review.

Authors:  Hilary Weingarden; Keith D Renshaw
Journal:  J Affect Disord       Date:  2014-09-20       Impact factor: 4.839

7.  [Influence of the psyche on cosmetic treatments].

Authors:  L Höfel
Journal:  HNO       Date:  2015-01       Impact factor: 1.284

8.  Development and Validation of the Body-Focused Shame and Guilt Scale.

Authors:  Hilary Weingarden; Keith D Renshaw; June P Tangney; Sabine Wilhelm
Journal:  J Obsessive Compuls Relat Disord       Date:  2016-01-01       Impact factor: 1.677

Review 9.  Cosmetic Presentations and Challenges of Body Dysmorphic Disorder and Its Collaborative Management.

Authors:  Swathi Shivakumar; Mohammad Jafferany; Sneha Sood; V Sushruth
Journal:  J Cutan Aesthet Surg       Date:  2021 Jan-Mar
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.